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ABSTRACT
MALLORY BROOKE HARMON: The Role of the AGE/RAGE Signaling Pathway in
Cardiac Fibroblast Migration
(Under the direction of Dr. James A. Stewart, Jr.)
Diabetes is one of the leading causes of death in the United States with around 30
million who suffer from diabetes and 84 million who are considered pre-diabetic.
Diabetic individuals are at an increased risk for developing cardiovascular disease due to
a stiffening of the left ventricle, which is thought to occur through fibroblast “activation”
mediated by increased AGE/RAGE signaling. Advanced glycated end products (AGEs)
accumulate within the body overtime and are accelerated under hyperglycemic
conditions, and AGEs exert their effects by binding to their receptor (RAGE). Fibroblast
“activation” is marked by elevated levels of α-smooth muscle actin expression and an
increase in cell migration. While “active” fibroblast migration is increased during wound
healing in a healthy individual, diabetics have decreased fibroblast migration to prolong
wound healing. Therefore, the goal of this study was to determine how the AGE/RAGE
signaling pathway impacts cell migration in non-diabetic and diabetic cardiac fibroblasts.
Using isolated cardiac fibroblasts from non-diabetic and diabetic mice, migration was
assessed with a migration assay. Diabetic fibroblasts have an increase in migration
compared to non-diabetic fibroblasts whereas inhibiting the AGE/RAGE signaling
pathway leads to a significant increase in fibroblast migration. The results suggest that
the AGE/RAGE signaling cascade plays a role in cardiac fibroblast migration.
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CHAPTER I
INTRODUCTION
Diabetes Mellitus: Type I and Type II
Each year, 1.5 million Americans are diagnosed with the 7th leading cause of
death: diabetes.1 Diabetes is a disease associated with persistent high blood glucose levels
and non-sufficient insulin levels. Insulin is a hormone that is released from beta-cells in
the pancreas in response to elevated blood glucose levels. Once released, insulin binds to
the insulin receptor which leads to the uptake of glucose from the blood; therefore,
insulin is a key component in maintaining blood glucose levels. Diabetes mellitus exists
in two different clinical conditions: type I and type II. While both types of diabetes
involve insulin complications, they differ in their physiology. Type I diabetes, or insulindependent diabetes, is an autoimmune disease that leads to a loss of insulin production
due to the destruction of pancreatic beta-cells resulting in chronic high blood sugar or
hyperglycemia. Type II diabetes is more common than type I with predictions of plaguing
more than 439 million people by the year 2030.2 Type II diabetes is commonly a result of
unhealthy lifestyles and environmental factors that may lead to a lifetime of both longand short-term diabetic complications. In severe cases, uncontrolled type II diabetes can
lead to death. Also referred to as non-insulin dependent diabetes, type II diabetes occurs
when insulin receptors become desensitized to insulin due to overexposure to high blood
glucose levels. As a result, beta-cells may continue to produce insulin resulting in
hyperinsulinemia.3 Consequently, a type II diabetic individual will have both increased

1

circulating levels of glucose and insulin without a functional mechanism in play to
combat this issue. The prolonged presence of high blood glucose circulating through the
cardiovascular system can lead to damages in many vital physiological functions of
organs throughout the body, especially the heart.4

Diabetes and Cardiovascular Disease
Diabetics commonly suffer from complications as a result of their diabetes, such
as cardiovascular disease. At least sixty-eight percent of people age sixty-five or older
with diabetes die from some form of heart disease.4 Adults with diabetes are two to four
times more likely to die from heart disease than adults without diabetes.4 Common types
of cardiovascular disease associated with diabetes are left ventricle hypertrophy or
increased muscle mass, poor heart function, and increased fibrosis.5,6 In type II diabetics,
left ventricle hypertrophy is a strong predictor of heart failure.5 Studies have shown that a
direct relationship can occur between increased left ventricle wall thickness and the
likelihood of heart failure.7 The thickness of the left ventricle along with fibrosis restricts
diastolic function in which the heart fills with blood to then be pumped throughout
systemic circulation. One possible mechanism associated with left ventricle hypertrophy
is myocardial remodeling in which a variety of cells within the heart alter the
extracellular matrix (ECM) composition.5 Fibrosis is defined as the excessive deposition
of ECM within tissues and is a common complication of diabetes.6 Studies have shown
that cardiac tissue taken from type II diabetics with no other disease risk factors, such as
hypertension or coronary artery disease, had an increased amount of interstitial fibrosis
compared to non-diabetic individuals.6
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Extracellular Matrix Composition and Remodeling
Cardiac fibroblasts are one of the most abundant cells in the heart and are credited
with secreting the components that together form the ECM.8 The ECM includes
molecules, such as collagens, fibronectin, laminin, elastin, proteoglycans, and other
proteins.9 While all cells are able to modulate the ECM, due to their secretory ability,
cardiac fibroblasts have been demonstrated to be the primary cell type responsible for
maintaining and modifying the ECM in response to both extracellular and intracellular
stimuli.10,11 Active cardiac fibroblasts are referred to as myofibroblasts and can be
detected due to increased levels of α-smooth muscle actin (α-SMA), increased cell
migration, and increased ECM production.12 When wounds occur, fibroblasts will secrete
signals, such as matrix metalloproteases (MMPs) and tissue inhibitors of matrix
metalloproteases (TIMPs).13 These signals are able to activate neighboring fibroblast
cells to differentiate into myofibroblasts which migrate and actively remodel through
increasing ECM production resulting in fibrosis.10,14 While MMPs are elevated in wound
healing, the mechanism of action explaining this abundance is not yet known.10
Myofibroblasts are not commonly found in large numbers in hearts of healthy
individuals; however, myofibroblasts are observed in greater numbers in the hearts of
individuals with diabetes.6,8 The prolonged presence of high glucose levels along with
increased MMPs and TIMPs alter the functionality of the myofibroblasts in type II
diabetics.10,11,13

AGE/RAGE Cascade
Advanced glycated end products (AGEs) are formed through a non-enzymatic
reaction in which sugar molecules and proteins are combined.15 AGEs accumulate
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naturally in the body and increase with age.15,16 While present in a lesser degree in
healthy individuals, AGEs accumulate at a higher rate and are more abundant in
individuals suffering from diabetes due to increased glucose levels.15,17 The accumulation
of AGEs can lead to an increase in the crosslinking of matrix proteins contributing to the
rigidity of the ECM.15,18 In addition, AGEs can elicit an intracellular signal by binding
and activating their corresponding receptor (RAGE; Receptor for Advanced Glycated
End products).18 When activated, the AGE/RAGE cascade stimulates growth factor
secretion and increased collagen production along with upregulation of RAGE expression
on the cellular membrane,19 Figure 1. The AGE/RAGE cascade also increases oxidative
stress and inflammation when activated.18,20 The loss of cellular elasticity associated with
the activation of AGE/RAGE signaling affects the physiological function of many tissues
and organs.21 For instance, studies have shown that the AGE/RAGE cascade produced
endothelial dysfunction in coronary arterioles in type II diabetic mice.22 When activated,
the AGE/RAGE cascade subsequently stimulates the cardiac fibroblast to myofibroblast
transition resulting in increased ECM production or fibrosis leading to the development
of cardiovascular disease such as left ventricle stiffness commonly observed in diabetic
patients.19
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Figure 1. AGE/RAGE Signaling Pathway. Advanced Glycated End Products
(AGEs) binding to their receptors (RAGEs) will initiate the AGE/RAGE signaling
cascade resulting in increased fibroblast differentiation, collagen production, and
changes in fibroblast migration. Rap1a intersects the AGE/RAGE cascade to increase
diabetes-induced pathway outcomes.
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Rap1a
The repressor/activator protein 1a (Rap1a) homologue is associated with different
organ systems and multiple signaling pathways, such as the cardiovascular signaling
pathways. In the cardiovascular signaling pathway, Rap1a is necessary to maintain proper
development and functionality of the heart.23 Rap1a is a member of the Ras superfamily.
The Ras superfamily is composed of small GTPases that each contain a conserved G
domain in which guanine trinucleotide phosphate (GTP) is bound and hydrolyzed to
guanine dinucleotide phosphate (GDP).24 Due to its ability to act as molecular switch
and alter its location on the plasma membrane, Rap1a is able to connect and transmit
extracellular signals to intracellular signals.24,25 In respect to the cardiovascular system,
exchange proteins activated by cAMP (EPACs) later cause Rap1a to become active.26
Rap1a cycles between its active and inactive states which affects its binding to an
assortment of proteins including cardiovascular effector proteins.24 These effector
proteins regulate mechanisms like cell adhesion, cell proliferation, and cell migration
within cardiovascular tissues.24 Under hyperglycemic conditions, Rap1a has been shown
to activate the downstream signaling pathways, such as extracellular signal-regulated
kinases 1/2 (ERK1/2),19,25 Figure 1. This activated pathway has been demonstrated to
stimulate ECM fibrosis, which results in cardiovascular disorders.19 Based off initial
studies, Rap1a appears to be involved in the AGE/RAGE cascade which leads to the
activation of cardiac fibroblasts. Activation of cardiac fibroblast leads to ECM
remodeling with the possibility of excess fibrous connective tissue or fibrosis occurring
within the heart.
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Fibroblast Migration
Migration of cells is an integral part in the structure and function of body systems.
Cells, such as cardiac fibroblasts, will alter their phenotypes and change their rates of
migration when activated.27 Myofibroblasts are characterized by increased contractile
properties along with increased motility and collagen production.6 Following an injury,
fibroblasts are activated by chemical factors such as cytokines and growth factors.28
These activated fibroblasts (myofibroblasts) migrate to stimulate wound healing and scar
formation.29 While functional in normal individuals, this migratory mechanism of action
is dysfunctional in individuals suffering with diabetes.30,31 In diabetics, fibroblasts are
activated but do not display their expected migratory ability.10 For instance, studies have
shown that oxidative stress induced by high glucose levels irregularly activated a basic
fibroblast growth factor (bFGF) signaling protein, Rac1, to decrease fibroblast cell
migration.29,32 The slow fibroblast migration described is demonstrated through delayed
wound healing in diabetics.30,31 While one would expect increased migration due to the
presence of myofibroblasts, studies have shown that diabetic fibroblast migration is
impaired when compared to wild-type fibroblast migration.10 In contrast, recent literature
findings have reported that hyperglycemic conditions increased migration in rat cardiac
fibroblasts.33 These results demonstrate conflicting outcomes regarding diabetes and its
effects on migration.33 Therefore, one goal of this project was to determine the effects of
diabetes on cardiac fibroblast migration.
Although it is widely recognized that diabetics have problems with wound healing,
the factors that signal fibroblast migration remain unknown. The specific purpose of this
project was to examine the effect of the AGE/RAGE signaling cascade on cardiac
fibroblast migration in diabetics. More specifically, this project was designed to study the
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role of AGE-mediated migration in fibroblasts with and without active RAGE signaling
in primary cultures of cardiac fibroblasts. We hypothesized activation of the AGE/RAGE
cascade alters cardiac fibroblast migration in type II diabetic mice. Using genotypically
different cardiac fibroblasts on collagen matrices from diabetic and nondiabetic mice, we
will be able to observe ECM remodeling and cell mobility to determine a mechanistic
role for RAGE in diabetes-induced fibroblast migration.
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CHAPTER II
METHODS
Animal Models
Diabetic Mouse Model (db/db)
Male Leprdb (db/db) type II diabetes mellitus mice (BKS.Cg-Dock7m +/+ Leprdb/J,
Jackson Labs) were used for this study. This mouse model has a G→T point mutation in
the leptin receptor rendering it nonfunctional. The mutation was caused by an insertion of
a 106 nucleotide in the leptin receptor mRNA transcript with a stop codon resulting in
premature stopping of expression. The long intracellular domain translated by the intact
leptin receptor mRNA has been demonstrated to be crucial for initiating intracellular
signal transduction, and insertion of the premature stop codon results in loss of long
domain expression to lead to the Ob-R isoform.34 Leptin signaling cascade activation in
the central nervous system alerts the animal that there is abundant energy and to halt
further food intake. With this mutation, the leptin receptor loses its sensitivity to leptin as
well as its communication function. The mice continued to eat, eventually resulting in
obesity and insulin resistance, which are two key characteristics of type II diabetes
mellitus. The mice developed hyperglycemia by 8-weeks of age, overt diabetes by 12weeks of age, and shared many other common features with type II diabetes mellitus
patients, including hyperglycemia, obesity, and insulin resistance. Heterozygous mice
(db/wt) were used as lean controls. Our work and other research has shown that these
mice cannot be distinguished morphologically or physiologically from wild type mice.22
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RAGE Knockout Mouse Model (RAGE-/-)
Male RAGE knockout mice (RAGE-/-) were used for this study. This mouse
model was generated by flanking exons 2-7, which encode the extracellular domain of the
receptor, by two loxP sites in the same orientation.35 After exposure to Cre recombinase
(Cre), the loxP flanked sequences were deleted.35 The mutation resulted in a loss of
RAGE mRNA expression, and therefore, loss of RAGE signaling. RAGE knockout mice
were crossbred with heterozygous (db/wt) mice to generate RAGE knockout diabetic
(db/dbRKO) and nondiabetic (db/wtRKO) mice. RAGE knockout diabetic mice developed
hyperglycemia by 8-weeks of age, overt diabetes by 12-weeks of age, and shared many
other common features with type II diabetes mellitus patients including hyperglycemia,
obesity, and insulin resistance. Heterozygous mice were used as lean controls. As with
the db/wt mice, our work has shown that these mice cannot be distinguished
morphologically or physiologically from wild type mice.

Rap1a Knockout Mouse Model (Rap1a-/-)
Male Rap1a knockout mice (Rap1a-/-) and wildtype (Rap1a+/+) were used for
this study. This mouse model was generated by inserting a neomycin resistant gene
downstream of exon 4 of rap1a in the opposite (3’-5’) orientation.36 A targeting vector (a
0.95 kb PvuII-NdeI fragment) was used to insert the resistance gene in order to disrupt
rap1a mRNA expression.

Animal Care
All experiments were performed using adult male mice at 16-weeks of age. The
mice were housed under standard environmental conditions and maintained on
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commercial mouse chow and tap water ad libitum. All studies conformed with the
principles of the National Institutes of Health “Guide for the Care and Use of Laboratory
Animals,” (NIH publication No. 85-12, revised 1996), and the protocol was approved by
the University of Mississippi Health Sciences Center Animal Care and Use Committee
(protocol #17-024). Anesthesia for euthanasia at the experimental endpoint was caused
by carbon dioxide inhalation. Cervical dislocation served as a second mechanism for
euthanasia after carbon dioxide inhalation. At this time, the chest was opened, and the
heart was quickly excised for further cellular, histological, and biochemical experiments.

Genotyping
Tail Digestion
In order to identify the genotype of the mice, a few millimeters (~3-5 mm) of each
tail were cut and placed in a 1.5 mL microcentrifuge tube with 250 µL of a DNA
extraction buffer solution, an alkaline lysis buffer solution (50mM NaOH diluted in
H2O). While in the lysis buffer, the tail was cut into fine pieces with scissors, and each
tube was placed in a heat block at 95°C for 1 hour. After the 1-hour digestion, the tubes
were centrifuged at 14,000 x g for 5 minutes at room temperature. Once completed,
96.4µL of the supernatant was transferred to a new 1.5 mL microcentrifuge tube
containing 8 µL of 8mM Tris-HCl buffer solution (pH 8.8). Forward and reverse primers,
as well as the thermocycler protocol for the genotyping of the mice, are given below.

Db Genotyping
In order to genotype the leptin receptor (Db genotyping) in diabetic and
nondiabetic mice, a specific polymerase chain reaction (PCR) was completed. The PCR
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master mix for each individual sample included 15 µL of 2X Dream Taq Hot Start Mix, 1
µL of Forward Primer (Db-F: AGAACGGACACTCTTGAAGTCTC), 1 µL of Reverse
Primer (Db-R2: GGCCACAAAATATACACTTCTCTAATAAGCTC), and 12 µL of
nuclease-free water. 29 µL of master mix was added to separate PCR tubes, and then 1
µL of each DNA sample was added to the proper designated tube. Each PCR master mix
component was multiplied by the number of DNA samples present. After the master mix
and DNA were added to the PCR tubes, each tube was placed in the thermocycler
(Applied Biosystems Pro-Flex Thermocycler) programmed according to the table below.
Table 1. PCR steps for db genotyping
Temperature
94˚C
94˚C
53˚C
72˚C
72˚C
4˚C

Time
5 min
30 sec
30 sec
30 sec
5 min
Hold

Cycles
X1
X 30
X1

After the first step of the Db PCR was completed, the DNA was cleaned up by
adding 50 µL of binding buffer (Qiagen; Fermentas GeneJet PCR Purification Kit
#K0702), 50 µL of isopropanol, and 30 µL of PCR product into a chromatography
column, which was placed in a 1.5 mL microcentrifuge tube. The microcentrifuge tube
including the column was spun for 60 seconds at 12,000 x g in centrifuge (HeraeusThermo Centrifuge). The effluent flow-through was discarded, and 700 µL of wash
buffer (Qiagen; Fermentas GeneJet PCR Purification Kit #K0702) was added to the
column. The microcentrifuge tube including the column was spun again for 60 seconds at
12,000 x g. The effluent flow-through was again discarded. The microcentrifuge
including the column was spun once more to remove traces of wash buffer. Then, the
column was placed in a new 1.5 mL microcentrifuge column, and 50 µL of elution buffer
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(Qiagen; Fermentas GeneJet PCR Purification Kit #K0702) was added to the column.
The microcentrifuge tube including the column was spun for 60 seconds at 12,000 x g.
A second PCR reaction was run using the cleaned DNA. The master mix included
15 µL of 2x Taq Mix, 1 µL of Forward Primer (Db-F:
AGAACGGACACTCTTGAAGTCTC), 1 µL of Reverse Primer (Db-R1:
CATTCAAACCATAGTTTAGGTTTGTGT), and 12.5 µL of nuclease-free water. 29.5
µL of master mix was added to separate PCR tubes, and then, 2 µL of each PCR product
was added to the proper designated tube. Each PCR master mix component was
multiplied by the number of DNA samples present. After the master mix and DNA were
added to the PCR tubes, each tube was placed in the thermocycler programmed according
to the same table as before for the first PCR reaction.
After the second PCR was completed, the DNA was digested by adding 1.5 µL of
10X Tango Yellow Buffer (Thermo Fisher), 1.5 µL of RsaI (10 U/L, Thermo Fisher), and
3.5 µL of nuclease-free water. 8.5 µL of master mix was added to separate PCR tubes,
and then, 6.5 µL of each PCR product was added to the proper designated tube. The tubes
were placed in the thermocycler for 6 hours at 37°C. The RsaI restriction enzyme
isolated from Rhodopseudomonas sphaeroides recognizes GT^AC sites and cleaves
generated PCR products from the second step leptin receptor (Db) genotyping.
Next, a 3% agarose gel was made by mixing 1.5 grams of agarose (Thermo
Fisher) with 50 mL of TAE (Thermo Fisher). The mixture was microwaved until the
agarose powder was solubilized. Then, 8.5 µL of ethidium bromide was added to the
mixture before pouring into a gel electrophoresis tray. Once in the tray, a comb was
added. After the gel polymerized, 15 µL of PCR products were mixed with 3 µL of dye.
17 µL of dye + PCR mixture were added to each well in the 3% agarose gel.
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Additionally, 5 µL of dye + 5 µL DNA ladder (Thermo Fisher) was added to a separate
well to run as a DNA ladder. Lastly, the gel was run at 100 volts for 60 minutes to
separate PCR products. The gel was visualized for leptin receptor (Db) genotyping using
an IBright™ CL100 Imagine System. A 135bp band indicates a knockout (db/db)
diabetic mouse. A 187bp band indicates a wild type (Db/Db) mouse. When both 135bp
and 187bp bands are present, it indicates a heterozygote (Db/db) mouse.

Rap1a Genotyping
In order to genotype the Rap1a mice, a PCR master mix for each individual
sample included 15 µL of 2X Dream Taq Hot Start Mix, 1 µL ADPR266 (5´‐
TCTATCGCCTTCTTGACGAGTTC -3´), 2 µL Rap1aKO (5´‐
CTTGCTCTCCTGTTACCTATAGGTGCC -3´), 1 µL RapExon (5´‐
CCGTAAAATCTGTTCTCTCAAGTC -3´), and 12.0 µL of nuclease-free water. 28 µL
of master mix was added to separate PCR tubes, and then, 2 µL of each DNA sample was
added to the proper designated tube. Each PCR master mix component was multiplied by
the number of DNA samples present. After the master mix and DNA were added to the
PCR tubes, each tube was placed in the thermocycler programmed according to the table
below.
Table 2. PCR steps for Rap1a genotyping
Temperature
93˚C
93˚C
57˚C
65˚C
65˚C
4˚C

Time
1.5 min
30 sec
30 sec
3 min
3 min
Hold
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Cycles
X1
X 40
X1

Once the PCR was complete, a 2% agarose gel was created by mixing 1 gram of
agarose (Thermo Fisher) with 50 mL of TAE (Thermo Fisher). The mixture was
microwaved until dissolved, and then 8.5 µL of ethidium bromide was added before
pouring into a gel electrophoresis tray. Once in the tray, a comb was added. After the gel
polymerized, 15 µL of PCR products were mixed with 3 µL of dye. 17 µL of dye + PCR
mixture were added to each well in the 2% agarose gel. Additionally, 5 µL of dye + 5
DNA µL ladder (Thermo Fisher) was added to a separate well to run as a DNA ladder.
Lastly, the gel was run at 100 volts for 60 minutes to separate PCR products. The gel was
visualized for Rap1a genotyping using an IBright™ CL100 Imagine System. A 1107bp
band indicates a knockout (Rap1a-/-) diabetic mouse. A 1358bp band indicates a wild
type (Rap1a+/+) mouse. When both 1107bp and 1358bp bands are present, it indicates a
heterozygote (Rap1a+/-) mouse.

RAGE Genotyping
In order to genotype the RAGE mice, a PCR master mix for each individual
sample included 15 µL of 2X Taq Mix, 1 µL mRAGE e3-Forward (5´‐
CACAGGAAGAACTGAAGCTTGGAAGG -3´), 1 µL mRAGE e5-Reverse (5´‐
CACCTTTGCCATCGGGAATCAGAAG -3´), and 14 µL of RNA water. 29 µL of
master mix was added to separate PCR tubes, and then, 1 µL of each DNA sample was
added to the proper designated tube. Each PCR master mix component was multiplied by
the number of DNA samples present. After the master mix and DNA were added to the
PCR tubes, each tube was placed in the thermocycler programmed according to the table
below.
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Table 3. PCR steps for RAGE genotyping
Temperature
94˚C
94˚C
58 or 53˚C
72˚C
72˚C
4˚C

Time
5 min
30 sec
30 sec
30 sec
5 min
Hold

Cycles
X1
X 30
X1

Once the PCR was complete, a 1% agarose gel was created by mixing 1 gram of
agarose (Thermo Fisher) with 50 mL of TAE (Thermo Fisher). The mixture was
microwaved until dissolved, and then 8.5 µL of ethidium bromide was added before
pouring into a gel electrophoresis tray. Once in the tray, a comb was added. After the gel
polymerized, 15 µL of PCR products were mixed with 3 µL of dye. 17 µL of dye + PCR
mixture was added to each well in the 1% agarose gel. Additionally, 5 µL of dye + 5 µL
DNA ladder (Thermo Fisher) was added to a separate well to run as a DNA ladder.
Lastly, the gel was run at 100 volts for 20 minutes to separate PCR products. The gel was
visualized for RAGE genotyping using an IBright™ CL100 Imagine System. A 605bp
band indicates a wild type (RAGE+/+) mouse and a heterozygote (RAGE+/-) mouse.
An additional genotype protocol was performed on the RAGE mice as an internal
control. This procedure detected the presence of the GFP (green fluorescent protein)
fragment inserted into the Cre-loxP as a marker for RAGE knockout. A PCR master mix
for each individual sample included 15 µL of 2X Taq Mix, 1 µL EGFP36-54 (5´‐
GGTGCCCATCCTGGTCGAG -3´), 1 µL EGFP346-328 (5´‐
CGAACTTCACCTCGGCGCG -3´), and 14 µL of RNA water. 29 µL of master mix was
added to separate PCR tubes, and then 1 µL of each DNA sample was added to the
proper designated tube. Each PCR master mix component was multiplied by the number
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of DNA samples present. After the master mix and DNA were added to the PCR tubes,
each tube was placed in the thermocycler programmed according to the table below.
Table 4. 2nd PCR steps for RAGE genotyping
Temperature
94˚C
94˚C
56˚C
72˚C
72˚C
4˚C

Time
5 min
30 sec
30 sec
45 sec
10 min
Hold

Cycles
X1
X 35
X1

Once the PCR was complete, a 1% agarose gel was created by mixing 1 gram of
agarose (Thermo Fisher) with 50 mL of TAE (Thermo Fisher). The mixture was
microwaved until dissolved, and then 8.5 µL of ethidium bromide was added before
pouring into a gel electrophoresis tray. Once in the tray, a comb was added. After the gel
polymerized, 15 µL of PCR products were mixed with 3 µL of dye. 17 µL of dye + PCR
mixture were added to each well in the 1% agarose gel. Additionally, 10 µL of dye +
DNA ladder (Thermo Fisher) was added to a separate well to run as a DNA ladder.
Lastly, the gel was run at 100 volts for 30 minutes to separate PCR products. The gel was
visualized for Rap1a genotyping using an IBright™ CL100 Imagine System. A 310bp
band indicates a RAGE knockout (RAGE-/-) mouse or a heterozygote (RAGE+/-) mouse.

Fibroblast Isolation and Cell Culture
Mice were euthanized by CO2 exposure followed by cervical dislocation as a
secondary mechanism. The mice were weighed, dipped in 70% ethanol to sterilize, and
placed on a dissecting mat. Blood glucose readings were obtained from clipping the tip of
the mouse tail and placing a drop of blood on glucose test strips to be measured by the
blood glucose meter (glucometer; OneTouch Ultra®, LifeScan, Inc., Johnson &
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Johnson). The chest cavity of the mouse was then opened, and the heart removed,
weighed, and placed in cold 1X non-sterile PBS (phosphate buffered saline; 17mM NaCl,
0.3mM KCl, 1.01mM Na2HPO4, 0.18mM KH2PO4, pH=7.4) on ice. On average, three
hearts of each genotype were used for a single fibroblast isolation.11 In a sterile, cell
culture hood, the hearts were cut into small pieces in a 60mm petri dish. The pieces of the
heart were washed 3 times with 1X sterile PBS. Then, 5 mL of a collagenase-trypsin
enzymatic solution (0.1% Trypsin, Gibco; 100U/mL collagenase II, Worthington
Biochemical) was added to the heart tissue. The heart tissue-enzymatic mixture was
placed in a double-jacketed spinner flask containing a magnetic stir bar. Water was
continuously circulated through the spinner flask at 37°C to maintain optimal digestion
conditions. The tissue-enzymatic mixture was vigorously stirred for 10 minutes followed
by pipetting with a transfer pipette. After 10 minutes, the tissue-enzymatic mixture was
removed from the spinner flask and strained into a 50mL conical tube using a 100 µm
sterile disposable cell filter (Thermo Fisher). Tissue remaining in the strainer was placed
back in the spinner flask along with 5mL of enzymatic mixture. In the conical tube
containing the cell suspension from heart tissue, 5mL of “Stop” medium (high glucose
media; Dulbecco’s Modified Eagles Medium (DMEM) containing 4.5g/L glucose,
sodium pyruvate, L-glutamine, and supplemented with 14.2mM NaHCO3, 14.9mM
HEPES, 30% heat-inactivated fetal bovine serum (FBS), 1% L-glutamine, and 0.02%
Primocin (Thermo Fisher)) was added. The tube containing the cells was then centrifuged
at 170 x g for 10 minutes. The supernatant was suctioned off, and the cells pelleted at the
bottom of the tube were resuspended in high-glucose DMEM media containing 15% FBS
and stored in a 37°C incubator until completion of fibroblast isolation protocol. This
conical tube was considered the cell stock suspension, and all subsequent harvests were
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placed in the stock tube. This cycle was repeated until no heart tissue remained after
straining. The stock solution containing the cell suspension was centrifuged at 170 x g for
10 minutes. The cells were suspended in high glucose DMEM media and plated into
60mm petri dishes. After 24 hours, the cardiac fibroblasts were washed with their
appropriate media 3 times and incubated at 37°C in their appropriate media. Fibroblasts
from diabetic animal model were maintained in a 15% FBS high glucose DMEM (4.5g
glucose/L). Nondiabetic fibroblasts from heterozygous and wildtype animal groups were
maintained in a 15% normal glucose DMEM (1g glucose/L). All experiments were
performed using cells at P1, in order to maintain their original phenotypes. A visual
confirmation was performed for cell type determination. Cells were passaged just prior to
reaching 95% confluency using a 0.25% trypsin, 0.1% ethylenediaminetetraacetic acid
(trypsin/EDTA) solution (Life Technology). Plates were kept in a CO2 incubator at 37°C.
The media of each cell plate was changed every other day until used in experiments.

Collagen Extraction
Tails from diabetic (db/db), nondiabetic (db/wt), diabetic RAGE knockout
(db/dbRKO), nondiabetic RAGE knockout (db/wtRKO) were collected and stored at -20oC.
After roughly 20 tails had been collected, the tails were thawed on ice in 70% ethanol to
sterilize. The skin was removed from the tail to expose the tendons. The four major
tendons were excised from the tail and placed in dH2O on ice. After all the tendons were
isolated, the dH2O was removed, and 20mL acetic acid (1:1000 dilution in dH2O) was
added to the plate. The tendons and acetic acid were then transferred to a 50mL conical
tube. The tendons were then used to cut up into small pieces. After mincing, the tendon
pieces and acetic acid were placed into 200mL Erlenmeyer flask. The volume was
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brought up to 150mL with 1:1000 acetic acid.37 A stir bar was added to the flask, and the
flask was then placed on a stir plate at 4°C. The tendon-acetic acid solution was mixed
for 3 days (72 hours). All steps, hereinafter, were conducted in sterile conditions in a cell
culture hood. After 3 days, the tendon-acetic acid solution (now referred to as the
collagen solution) was brought into a sterile hood and poured into 4-50mL conical tubes.
These tubes were then centrifuged at 3000 x g for 30 minutes at 4°C. The supernatant
was removed and placed into new 50mL conical tubes and recentrifuged at 3200 x g for
30 minutes at 4°C. After the second spin, the supernatant was removed from each tube
and placed in a 200mL sterile beaker before being divided evenly between 3-50mL
conical tubes to be stored at 4°C until use.
Collagen concentration was estimated using Sircol™ Soluble Collagen Assay Kit
(Biocolor Ltd) as per manufacturer’s directions. Briefly, 1mL of Sircol™ dye reagent and
100µL of a collagen sample were added to a 1.5mL microcentrifuge tube and mixed
continuously for 30 minutes to form a collagen-dye complex. Tubes were then
centrifuged for 10 minutes at 12,000 x g. Tubes were then inverted and excess dye
drained away from pelleted collagen-dye complex. The pellet was washed with cold PBS,
recentrifuged at 12,000 x g for 10 minutes, and drained. Excess fluid was removed using
cotton swabs. 250µL of a provided alkali buffer was used to release collagen bound dye.
When bound dye had been dissolved, sample absorbance was read at 555nm, and
concentrations were determined by linear regression of a standard curve.
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Migration Assay
A sterile 48-well cell culture plate was used for the migration assay. On the
bottom of each well, a line was drawn down the center with three hashmarks dividing the
well into areas of interest to be used for imaging. Next, 75µl of genotype-specific
collagen was added to the designated well in order to coat the bottom of the well. The
plate was incubated for 1 hour at 37°C. Then, each well was washed with 1X sterile PBS
to remove excess collagen. The experimental design for assessing migration used three
replicates per treatment.
Fibroblasts at P1 were then seeded onto the migration plates.38 Once the cells
were confluent and covered approximately 90-95%, which usually occurred between 2448 hours, the media was suctioned off from each well. Each well was scratched with the
tip of a 200µL pipet tip along the previously marked line through the center of each well
on the bottom of the plate. After scratching, the cells were rinsed with the appropriate
media containing 1.5% FBS. 500uL of the appropriate 1.5% FBS media was added to
each well. The cells were allowed to incubate for 24 hours after scratching. Images of
cells were taken at both 0 and 24 hours post scratching.

Immunohistochemistry
Cardiac fibroblasts were fixed with histology grade 4% paraformaldehyde for 10
minutes and then washed 2X with 1X non-sterile PBS. Cells were then incubated with
blocking solution (3% donkey serum, 2% BSA, 0.01% Triton X-100 in 1X PBS)
overnight at 4°C in a moist chamber. After 24 hours, actin primary antibody was added
(conjugated phallodin red) in 1:20 dilution and incubated for 24 hours at 4°C. After
incubation, primary antibody was removed by 3X washes with 1X PBS. DAPI (1:1000
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dilution) was added for 1.5 hours at room temperature in the dark. Excess DAPI was
removed by 3X washes with 1X PBS. Slides were mounted using Vectashield hard set
mounting media.

Imaging
At the 0-hour time point, pictures were taken to document the position of cells
prior to migration using a Zeiss Primovert microscope with camera (Zen Blue 2.3 edition,
Zeiss). Hashmarks along the scratch line were used to position the plate and mark areas
of interest for imaging, and non-overlapping regions of interest were captured for image
analysis at 24 hours post scratching. The culture plate was returned to the 37°C incubator
for 24 hours. Upon reaching the 24-hour time point, the plate was removed from the
incubator. The media was removed, and the cells were rinsed with 1X non-sterile PBS
before adding 4% paraformaldehyde fixative. The cells were fixed for 10 minutes at room
temperature in a fume hood. After 10 minutes, the fixative was removed, and the cells
were washed with 1X PBS. 1X PBS with 0.1% Trition-100 was added to the cells for 310 minute washes with continuous rocking motion to permeabilize the fixed cells. After
washes were complete, the 1X PBS-Trition-100 solution was removed, and the cells were
stained with 1% Brilliant Blue Coomassie stain for 10 minutes with continual rocking.
Finally, 24-hour post-scratching pictures of the cells were taken using the 0-hour time
point images as templates for the correct position.

Image Analysis
Adobe Photoshop Elements 2018 was used to superimpose 0-hour and 24-hour
time point images in order to draw lines around the scratched area. After the area without
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cells had been denoted by lines, the 0-hour image was deleted. Next, the number of cells
that had migrated across the lines drawn were counted and recorded for each well. All
scratches were normalized by calculating the area of the scratch using Image J. Once the
area was calculated, the number of migrated cells was divided by the area. Image J was
used to calculate the area after the space between the two lines denoting the scratch was
completely filled in manually. This process was completed twice for two separate images
which together showed approximately the total cell migration of one well.

Statistical Analysis
Differences in db and het, RKO het and RKO db, and Rap1a WT and Rap1a KO
migration on different collagens were determined by performing a Student t-test.
Differences across genotypes were determined by one-way analysis of variance
(ANOVA). GraphPad Prism 5 was used for all statistical analysis. Significance was
defined as p<0.05. Error bars represent ± standard error of the mean (SEM).
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CHAPTER III
RESULTS
Preliminary Experiments
Prior to investigating the changes in migration, preliminary experiments were
performed to determine the appropriate percentage of fetal bovine serum (FBS) to
maintain cell viability yet prevent cell division. Previous studies have demonstrated a
fibroblast viability can be maintained in a range of FBS percentages (i.e., 2%, 5%, 10%,
and 15%); however, from past laboratory work, it was determined low FBS percentages
were necessary to support cardiac fibroblast viability and migration without stimulating
the cells to divide.38 For our studies, we needed to repeat these previously published
works to determine the percentage of FBS needed for fibroblast migration. In order to
confirm this data, cardiac fibroblasts cells were plated on no collagen (plastic dish),
diabetic (db) collagen, or non-diabetic (het) collagen with varying FBS percentages (2%,
5%, 10%, and 15%). The cells were imaged and observed for factors such as cell division
and migration. Cardiac fibroblast division and migration occurred at all FBS percentages,
Figure 2A-B. With possible cell division occurring at 2% FBS, lower ranges of FBS
percentages (1%, 1.5%, 2%, and 2.5%) were subsequently tested. While literature stated
2% FBS to be the lowest concentration to support fibroblast migration, 1.5% proved to
support fibroblast migration without promoting cell division. As a result of these
preliminary experiments, 1.5% FBS was chosen as the standard concentration to be added
to both high glucose (HG, hyperglycemic media) and low glucose (LG, euglycemic
media) DMEM medias, Figure 2C.
24
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Figure 2. Effects of fetal bovine serum percentage (FBS%) on migration and proliferation of cardiac fibroblast cells.
(A) Cardiac fibroblast cells were plated onto no collagen (plastic dish), diabetic (db) collagen, or non-diabetic (het) collagen
in a range of FBS% (2%, 5%, 10%, and 15%) to determine the least FBS% needed to support migration. Red asterisks denote
cells that are actively migrating toward the scratched area. (B) Under similar growing conditions, cardiac fibroblasts cells were
shown to be undergoing division at 2% FBS, 5% FBS, 10% FBS, and 15% FBS. Red arrows denote cells possibly dividing.
2% FBS was chosen as the least FBS% to support migration while limiting proliferation. Further studies were conducted to
determine if FBS% lower than 2% would yield similar experimental outcomes. (C) Graph shows cardiac fibroblast migration
on no collagen (plastic dish), diabetic (db) collagen, or nondiabetic (het) collagen with FBS% ranging from 1% to 2.5%. 1.5%
FBS was chosen for its ability to support migration. The bar length corresponds to the amount of cardiac fibroblast migration
+ standard error of the mean. These findings are similar to those observed in the primary literature.33

Immunofluorescence staining was used to visualize changes in the actin
cytoskeleton orientation. Cardiac fibroblast actin was labeled with a directly conjugated
Phalloidin-Cy3 (red). DAPI is a fluorescent DNA stain that binds to adenine-thymine
(A-T) regions of double stranded DNA and used to visualize nuclei (blue). As shown in
Figure 3, the cytoskeletons of the cardiac fibroblasts were oriented toward the scratched
area demonstrating initiation of migration. Fibroblasts began to realign their actin
cytoskeleton in the direction of an insult or disruption in their local environment, such as
with a scratch migration assay. The actin microfilaments and filipodia of the fibroblasts
were demonstrated to be oriented towards the scratched areas. With the immunolabeling,
we were able to able to gain a more accurate perspective of the migration abilities of the
fibroblasts. Cytoskeletal rearrangement marked changes in migration due to a perceived
insult. These data confirmed the success of the migration-scratch assay. Going forward,
the same techniques were used to determine differences in migration between matrix
conditions and genotypes.
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Figure 3. 4′,6-diamidino-2-phenylindole (DAPI) and phalloidin immunofluorescence of migrating cardiac fibroblast
cells. (A) In this image, the cardiac fibroblast nuclei were stain blue using DAPI which binds to the A-T region of double
stranded DNA, and the actin cytoskeleton was stained red with phalloidin. Image was taken at 10X. White arrows denote
cytoskeleton orientation toward the scratched area. (B & C) Both images were taken at 20X for better views of actin
orientation. (D & E) Images are the same as panels B and C, respectively, but white arrows have been added to denote the
orientation of the cardiac fibroblast cytoskeleton toward the scratched area.

Cardiac Fibroblast Migration on No Collagen, db Collagen, and het Collagen
Non-Diabetic and Diabetic Cardiac Fibroblast Migration
Scratch assays were performed using non-diabetic and diabetic cardiac fibroblasts
plated onto no collagen (plastic dish), diabetic (db) collagen, and non-diabetic (het)
collagen. Upon cells reaching a 90-95% confluence, a scratch was administered to both
non-diabetic and diabetic cell genotypes. The cells remained in culture for 24 hours. They
were then fixed in 4% paraformaldehyde and stained using 1% Brilliant Blue Coomassie.
The number of cells migrating into the scratched area were counted, Figure 4. The
number of counted migrated cells was normalized to the area of the scratch within the
field of interest. The area of interest was demarked by red lines on Figure 4. Diabetic
cells significantly migrated into the scratched area when plated onto no collagen
(p=0.0144) and het collagen (p=0.0183) when compared to non-diabetic. Increased
migration was also recorded in diabetic cells plated on db collagen when compared to
non-diabetic cells; however, no significance was observed. These findings corresponded
to similar migration assay experiments documented in literature.38 In that, increased
cardiac fibroblast migration was reported in diabetic cells over that of non-diabetic cell
migration.
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Figure 4. Migration of diabetic and non-diabetic cardiac fibroblasts on no collagen
(plastic dish), non-diabetic (het) collagen, and diabetic collagen for migration
comparisons. Diabetic cells migrated more than non-diabetic cells. Significance was observed
between non-diabetic (het) and diabetic (db) cell migration when fibroblasts were plated on no
collagen (plastic dish) and non-diabetic (het) collagen. Diabetic cardiac fibroblasts displayed
increased migration when plated on diabetic (db) collagen as compared to non-diabetic (het)
cardiac fibroblasts. Red lines demark edges of the scratch prior to migration assay.
Significance was determined by Student’s t-test. Bars represent mean + SEM. Experimental
groups were done in replicate (n=5-7).
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Non-Diabetic RKO and Diabetic RKO Cardiac Fibroblast Migration
Scratch assays were performed using non-diabetic and diabetic cardiac fibroblasts
when RAGE was knocked out (RKO) in the mice. The same methods were used in the
migration assay of non-diabetic RKO and diabetic RKO cells as non-diabetic and diabetic
cells. The results of the non-diabetic RKO and diabetic RKO cardiac fibroblast migration
assay are seen in Figure 5. Non-diabetic RKO and diabetic RKO cardiac fibroblasts were
observed to have migrated on no collagen, db collagen, and het collagen. Diabetic RKO
cells migrated into the scratched area at a significantly greater number than the nondiabetic RKO cells, regardless of the collagen. In the absence of a collagen matrix and
on a het collagen matrix, diabetic RKO cells migrated significantly more than nondiabetic RKO cells (p=0.0361). On a diabetic collagen matrix, diabetic RKO cardiac
fibroblasts migrated significantly more than non-diabetic RKO cells (p=0.019).
Significance was calculated using a Student’s t-test and reported within the figures. These
findings indicate an increased fibroblast migration was reported in diabetic RKO cells
over that of non-diabetic RKO cell migration.
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Figure 5. Migration of non-diabetic RKO and diabetic RKO cardiac fibroblasts on no
collagen, non-diabetic (het) collagen, and diabetic collagen for migration comparisons.
Diabetic (db) RAGE knockout (RKO) cardiac fibroblasts had significantly greater migration
than non-diabetic (het) RKO when plated on no collagen (plastic dish), non-diabetic (het)
collagen, and diabetic (db) collagen. Red lines demark edges of the scratch prior to
migration assay. Significance was determined by Student’s t-test. Bars represent mean +
SEM. Experimental groups were done in replicate (n=4-5).
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Rap1a WT and Rap1a KO Cardiac Fibroblast Migration
Scratch assays were performed using Rap1a WT and Rap1a KO fibroblasts to
determine the role Rap1a plays in cell migration, Figure 6. Rap1a KO cells plated on
either het or db collagen migrated in significantly greater numbers than Rap1a WT cells.
On a het collagen matrix, Rap1a KO cardiac fibroblasts migrated significantly more than
Rap1a WT cells (p=0.0035). On a diabetic collagen matrix, Rap1a KO cardiac fibroblasts
migrated significantly more than Rap1a WT cells (p=0.0226). From ongoing work in the
laboratory, we have determined Rap1a inhibition will decrease the activity of the
AGE/RAGE cascade by reducing intracellular signaling mechanisms, like phosphokinase
C (PKC). Therefore, Rap1a KO fibroblast migration was similar to that of RKO cells.
Our data indicates migration was elevated in Rap1a KO fibroblasts as compared to Rap1a
WT cells. The degree of increased migration may not be as dramatic as that of RKO cells.
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Figure 6. Migration of Rap1a WT and Rap1a KO cardiac fibroblasts on no collagen,
non-diabetic (het) collagen, and diabetic collagen for migration comparisons. Rap1a
knockout (KO) cardiac fibroblasts migrated significantly greater than Rap1a wildtype (WT)
when plated non-diabetic (het) collagen and diabetic (db) collagen. Significance was not
observed when cells were plated on no collagen (plastic). Red lines demark edges of the
scratch prior to migration assay. Significance was determined by Student’s t-test. Bars
represent mean + SEM. Experimental groups were done in replicate (n=3-4).
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Migration Comparison of Fibroblast Genotypes on No Collagen, db Collagen, and
het Collagen
The migration graphs of each cell genotype were combined to determine overall
changes in migration on no collagen, non-diabetic collagen, and diabetic collagen, Figure
7. Non-diabetic RKO and diabetic RKO cardiac fibroblasts displayed the highest
migration of the three genotypes, which may be attributed to the absence of the RAGE
receptor. Displaying an intermediate migration pattern, Rap1a WT and Rap1a KO
migrated more than the non-diabetic and diabetic cells, which had the least migration;
however, Rap1a WT and Rap1a KO fibroblast migration was still less than the nondiabetic RKO and diabetic RKO cells. Consistent across the cell phenotypes, diabetic
fibroblasts migrated more than non-diabetic cells. In some cases, the observed differences
between diabetic and non-diabetic fibroblasts were significant. The genotypic differences
in migration may be attributed to the degree of downregulation of the AGE/RAGE
signaling cascade. For example, completely knocking out RAGE resulted in increased
migration, while partial downregulation of AGE/RAGE signaling with Rap1a KO yielded
increased migration in comparison to het and db cells.
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Figure 7. Migration comparisons were made across genotypes plated on no collagen (plastic), non-diabetic (het) collagen,
and diabetic collagen. (A) Significance was observed between non-diabetic (het) and diabetic (db) fibroblasts grown on nondiabetic (het) collagen. (B) Significance was observed between non-diabetic (het) RAGE knockout (RKO) and diabetic (db)
RAGE knockout (RKO) fibroblasts grown on non-diabetic (het) and diabetic (db) collagen. (C) Significance was observed
between Rap1a wildtype (WT) and Rap1a knockout (KO) fibroblasts grown on non-diabetic (het) and diabetic (db) collagen. The
y-axis scales for all graphs were set to the same number of cells per scratched area to demonstrate global changes between cell
phenotypes on different collagen. An arbitrary red line was placed at 2 migrated cells per scratched area as a point of reference
between graphs. Significance was determined by one-way ANOVA. Bars represent mean + SEM.

Cardiac Fibroblast Migration on No Collagen, db RKO Collagen, and het RKO
Collagen
Non-Diabetic and Diabetic Cardiac Fibroblast Migration
Scratch assays were performed using non-diabetic and diabetic cardiac fibroblasts
plated onto no collagen (plastic dish), diabetic RKO collagen, and non-diabetic RKO
collagen, Figure 8. Diabetic cells migrated into the scratched area to a greater degree than
the non-diabetic cells in all experimental conditions. Significance was observed when
cells were plated on no collagen (p=0.0144). Very little information exists regarding
fibroblast migration on RKO collagen. There was no migration significance observed on
RKO collagen while previous figures showed significance of non-diabetic and diabetic
cardiac fibroblasts on het collagen. From this data, we can gather diabetic and nondiabetic cells behave similarly on RKO collagen as on RAGE wildtype collagen. The
presence or absence of RAGE would be predicted to impact cell behavior; however, the
presence or absence of RAGE should not affect AGE accumulation in diabetic or nondiabetic animals. AGE concentrations should be similar despite variances in genotype.
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Figure 8. Migration of non-diabetic and diabetic cardiac fibroblasts on no collagen, het
RKO collagen, and db RKO collagen for migration comparisons. Diabetic cardiac
fibroblasts had significantly greater migration than non-diabetic (het) cells when plated on
no collagen. Significance was not observed when fibroblasts were plated on non-diabetic
(het) RAGE knockout (RKO) collagen and diabetic (db) RKO collagen. Red lines demark
edges of the scratch prior to migration assay. Significance was determined by Student’s ttest. Bars represent mean + SEM. Experimental groups were done in replicate (n=4-7).
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Non-Diabetic RKO and Diabetic RKO Cardiac Fibroblast Migration
Scratch assays were performed using RAGE knockout (RKO) non-diabetic and
RKO diabetic cardiac fibroblasts plated onto no collagen (plastic dish), diabetic RKO
collagen, and non-diabetic (het) RKO collagen. Diabetic RKO cells migrated into the
scratched area in significantly higher numbers than the non-diabetic RKO cells plated on
plastic (p=0.0361) and non-diabetic het RKO collagen (p=0.004). Higher migration was
also observed in diabetic cells plated on db RKO collagen as compared to non-diabetic
fibroblasts. Overall, the data remains consistent in that diabetic cardiac fibroblasts
migrate more than non-diabetic cardiac fibroblasts independent of which collagen matrix
present. The degree of migration was dependent upon the presence or absence of RAGE
on the fibroblasts.
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Figure 9. Migration of non-diabetic RKO and diabetic RKO cardiac fibroblasts on no
collagen, het RKO collagen, and db RKO collagen for migration comparisons. Diabetic
(db) RAGE knockout (RKO) cardiac fibroblasts had significantly greater migration than nondiabetic (het) RKO cells when plated on no collagen (plastic) and non-diabetic (het) RKO
collagen. Significance was not observed when fibroblasts were plated on diabetic (db) RKO
collagen. Red lines demark edges of the scratch prior to migration assay. Significance was
determined by Student’s t-test. Bars represent mean + SEM. Experimental groups were done
in replicate (n=4-5).
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Migration Comparison of Fibroblast Genotypes on No Collagen, db RKO Collagen,
and het RKO Collagen
Migration graphs of het, db, het RKO, and db RKO fibroblasts were compared on
no collagen (plastic dish), het RKO, and db RKO collagen, Figure 10. Non-diabetic RKO
and diabetic RKO cardiac fibroblasts had the greatest degree of migration as compared to
diabetic and non-diabetic RAGE wildtype cells. As previously demonstrated, this data
was consistent with RAGE wildtype and RKO fibroblast migration on db and het
collagen. Diabetic RKO cells tended to migrate more than non-diabetic RKO cells with
significance as measured by one-way ANOVA being noted on het RKO collagen.
Diabetic cells migrated more than non-diabetic cells; however, no significance was
denoted. Overall, non-diabetic and diabetic cardiac fibroblast cells migrated to a lesser
degree than non-diabetic RKO and diabetic RKO cells. This difference in migration was
thought to be accredited to the lack of RAGE presence on the RKO fibroblasts and not
changes in AGE accumulation.
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Figure 10. Migration comparisons were made across genotypes plated on no collagen (plastic), non-diabetic (het)
RAGE knockout (RKO) collagen, and RAGE knockout (RKO) diabetic (db) collagen. (A) Significance was not
observed between non-diabetic (het) and diabetic (db) fibroblasts. (B) Significance was observed between non-diabetic
(het) RAGE knockout (RKO) and diabetic (db) RAGE knockout (RKO) fibroblasts grown on non-diabetic (het) RAGE
knockout (RKO) collagen. The y-axis scales for all graphs were set to the same number of cells per scratched area to
demonstrate global changes between cell phenotypes on different collagen. An arbitrary red line was placed at 2 migrated
cells per scratched area as a point of reference between graphs. Significance was determined by one-way ANOVA. Bars
represent mean + SEM.

Overall, our results indicated diabetic fibroblasts migrated at greater rates than
non-diabetic cells. Fibroblasts under hyperglycemic settings have been documented to
have higher migration due to possible changes in fibroblast to myofibroblast phenotype3.
Knocking out RAGE in the fibroblasts increased the rate of cell migration in both
diabetic and non-diabetic RKO cells as compared to RAGE wildtype fibroblasts.
Additionally, the source of collagen impacted cell migration. Diabetic collagen was
presumed to have more AGEs than non-diabetic collagen; therefore, diabetic collagen
had a greater role in cell migration.
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CHAPTER IV
DISCUSSION
The specific purpose of this project was to examine the effect of the AGE/RAGE
signaling cascade on cardiac fibroblast migration in diabetic conditions. Although wound
healing is widely recognized as a diabetic complication, the alterations in the underlying
molecular and cellular mechanisms remain largely unknown. Fibroblast migration has
been demonstrated to be instrumental in the wound healing process; however, factors that
impact fibroblast migration in diabetes, such as the ECM and the AGE/RAGE signaling
cascade, remain understudied.14,39,40 This project was designed to study the role of AGEmediated migration in cardiac fibroblasts with and without active RAGE signaling.
Genotypically different cardiac fibroblasts were isolated and grown on collagen matrices
from diabetic and nondiabetic mice to determine a mechanistic role for RAGE in
diabetes-induced fibroblast migration. We found that knocking out the AGE/RAGE
cascade alters cardiac fibroblast migration in type II diabetic mice.

Preliminary Experiments
In order to culture fibroblasts, fetal bovine serum (FBS) is required to maintain
healthy, viable cells. At higher concentrations, FBS will also promote cell division.
Therefore, cell culture experiments are generally performed in a low serum to no serum
environment to prevent cell division due to the possibility that cell division may
inaccurately skew results. For this study, we tested multiple FBS percentages to
determine how much was needed to maintain fibroblast health and viability while
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limiting cell proliferation. FBS percentages ranging from 2%, 5%, 10%, and 15% were
added to the cardiac fibroblast cells for 24 hours after the plates were scratched. Previous
studies have reported using slightly higher FBS concentrations for migration assay
experiments.33 While our initial studies were performed to determine a working
percentage of FBS, we found the fibroblasts possibly divided at all percentages, but there
was limited proliferation occurring at 2% FBS. As a result, 1.5% FBS was determined to
promote 2D migration with little to no proliferation occurring to produce inaccurate
results when counting the number of migrated cells in the scratched area.
Cardiac fibroblasts must also modify their cellular shape by forming bleb-like
protrusions or filopodia, which consists of parallel actin filaments to push the plasma
membrane forward for migration to occur.41 Migration studies of human dermal
fibroblasts have displayed migration toward the wound bed by expressing thick actin
bundles thereby assuming myofibroblast phenotype.27 The filopodia or leading edges of
the actively migrating cardiac fibroblasts were visualized in Figure 3. The actin
microfilaments within the filopodia were oriented toward the scratched area indicating
the migratory ability and morphological changes of the cardiac fibroblasts.

Diabetic and Non-Diabetic Cardiac Fibroblast Migration
In this study, diabetic cardiac fibroblasts migrated more than non-diabetic cardiac
fibroblasts. This finding was unexpected as delayed wound healing and decreased
migration of dermal fibroblasts are hallmarks observed in diabetic patients.42 We found
that diabetic cardiac fibroblasts consistently demonstrated an increase in migration when
compared to non-diabetic cardiac fibroblasts.33 Elevated diabetic cardiac fibroblast
migration could be attributed to the heterogeneity of fibroblasts. Cells taken from
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differing tissues will retain their in vivo characteristics in culture resulting in a variance in
phenotypic responses to stimuli.43-45 Additionally, hyperglycemic media conditions (HG
DMEM with 1.5% FBS) may also play a role in altering migration levels in diabetic
fibroblasts. Studies have shown that culturing cells in a high glucose media can either
positively or negatively impact fibroblast migration and consequentially wound
healing.29,46 For example, studies performed by Xuan et al., described basic Fibroblast
Growth Factor (bFGF) as a key regulatory molecule capable of inhibiting human
fibroblast migration in diabetic conditions.29 In comparable studies, Shi et al., described
bFGF as a migration promotor in diabetic conditions.46 We aim to conduct future studies
to determine the effects of high glucose media on the migratory ability of non-diabetic
cardiac fibroblasts. In addition, studies will also be undertaken to determine the effects of
normoglycemic media on the migratory ability of diabetic cardiac fibroblasts. Should
hyperglycemic media conditions alter fibroblast migration, one would expect to observe
an increase in migration of non-diabetic cardiac fibroblasts cultured in high glucose
media compared to normal media. Hyperglycemia is also thought to impact cardiac
fibroblasts’ ability to contract the ECM. Previous studies have found that cardiac
fibroblasts grown in a hyperglycemic media had a greater effect on contraction of threedimensional collagen gel matrices.47 This increased contractile ability was credited to the
diabetic condition and glucose levels surrounding the fibroblast. If the hyperglycemic
conditions of these diabetic cardiac fibroblasts affected their contractile ability, then one
can conclude that hyperglycemic conditions are also a prominent factor to alter cardiac
fibroblast migration.
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AGE/RAGE Signaling Pathway
Advanced glycated end products (AGEs) naturally accumulate within the body;
however, AGEs accumulate more rapidly in diabetic individual.15 AGE serum levels in
diabetic patients have been recorded equaling nearly double the AGE serum levels in
healthy individuals.15 The effect of AGEs is mediated by their cell surface receptor
RAGE.15 RAGE is included in the immunoglobulin superfamily of cell surface
receptors.48 Together, AGEs along with RAGE receptors constitute a biological pathway
referenced as the AGE/RAGE signaling pathway. The AGE/RAGE signaling pathway
has been proven to increase collagen deposition; therefore, one can expect the
AGE/RAGE cascade to impact activation and migration of cardiac fibroblasts.19 By
studying the effects of the AGE/RAGE on migration of cardiac fibroblasts, we were able
to conclude that the AGE/RAGE signaling pathway decreased cardiac fibroblast
migration of both diabetic and non-diabetic cells. While little research has been
conducted on the AGE/RAGE cascade in relation to cardiac fibroblasts, the AGE/RAGE
cascade has been shown to inhibit migration of other cell types such as endothelial
progenitor cells.19 When the AGE/RAGE signaling pathway functioned naturally,
migration of diabetic and non-diabetic cardiac fibroblasts was at its lowest. Overall, one
can conclude that when the AGE/RAGE signaling pathway is fully functional, migration
of cardiac fibroblasts is hindered or decreased.

Non-Diabetic RKO and Diabetic RKO Cardiac Fibroblast Migration
In order to further study the effects of the AGE/RAGE signaling pathway,
fibroblasts isolated from RAGE knockout (RKO) mice were studied to determine if
changes in migration patterns existed and if these changes could be attributed to the
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AGE/RAGE signaling pathway. Without RAGE present, the signaling pathway will not
become stimulated in response to AGEs present on the diabetic collagen. Thus, the
absence of RAGE rendered the AGE/RAGE signaling cascade nonfunctional and
prevented intracellular responses attributed to the AGE/RAGE cascade. Overall, both
genotypes displayed increased migratory ability when compared to the other genotypes
we studied. Additionally, diabetic RKO cells were demonstrated to migrate more than
non-diabetic RKO cells. Studies have shown that when the RAGE receptor was absent in
diabetic mice, fewer diabetic complications, such as plaque build-up and atherosclerosis,
were observed.49 This increase in migration when the AGE/RAGE signaling pathway was
nonfunctional supports the hypothesis that the AGE/RAGE signaling cascade negatively
alters the migration of cardiac fibroblasts.

Rap1a WT and Rap 1a KO Cardiac Fibroblast Migration
The repressor/activator protein 1a (Rap1a) has been demonstrated to link
extracellular stimuli to intracellular effects.19,25 We proposed Rap1a was a point of
intersection within the AGE/RAGE signaling pathway. Changes in Rap1a activation may
modify the transduction strength of the AGE/RAGE pathway, and consequently, alter the
signaling outcomes. In order to test the downstream effects of Rap1a on migration,
studies were performed in which Rap1a levels were depleted through the use of small
interfering or silencing RNA (siRNA). These studies showed that when Rap1a
concentrations were diminished so was migration of human microvascular endothelial
cells.25 These findings differ from those observed in cardiac fibroblasts. We found
cardiac fibroblasts without Rap1a (Rap1a KO) to migrate into the scratched area more
than cardiac fibroblasts isolated from Rap1a wildtype (Rap1a WT). When comparing the
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Rap1a genotype to the other tested genotypes, Rap1a cardiac fibroblasts displayed an
intermediate migratory ability. This data supports the idea that Rap1a is an intersecting
protein in the AGE/RAGE signaling pathway, and the cell’s migration ability is mediated
through the AGE/RAGE cascade. Therefore, when present in the cell, Rap1a will
enhance the outcomes of the AGE/RAGE signaling pathway. In this case, AGE/RAGE
signaling in Rap1a WT mice had migration levels similar to that observed in non-diabetic
fibroblasts. In contrast, Rap1a KO fibroblasts had higher levels of migration, which we
suspect is due to loss of Rap1a influence on the AGE/RAGE signaling cascade.

Migration on db Collagen, het Collagen, db RKO Collagen, and het RKO Collagen
The extracellular matrix of cardiac fibroblasts is composed of many different
biological molecules, including different types of collagen, and often these molecules
will undergo post-translational modifications to alter the cell-matrix interactions resulting
in changes in migration patterns.41 In this study, we focused on both the changes in
migration caused by different cardiac fibroblast genotypes, as well as changes in the
migration of these cells on different types of collagen. Collagen was extracted from the
tails of diabetic, non-diabetic, diabetic RKO, and non-diabetic RKO mice. It has been
demonstrated that diabetics have an increased AGE accumulation in their cells as well as
increased amounts of AGEs present in their extracellular compartments.17 Other studies
have discovered crosslinking of AGEs produces a stiffer collagen matrix.50 Therefore,
with this study, we wanted to determine if collagen from diabetic or diabetic RKO mouse
tails could differentially alter changes in cardiac fibroblast migration. We found no
significant differences in fibroblast migration when cells of the same genotype were
plated on collagen from either RAGE wildtype or on collagen from RAGE knockout
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mice. In other words, the presence or absence of RAGEs most likely did not impact AGE
accumulation. However, differences were observed between diabetic and non-diabetic
cells as well as between RAGE wildtype and RAGE knockout cells. The lack of RAGE
signaling did cause collagen-dependent migration changes between cells of the same
genotype.

Summary and Conclusion
With this study, we found that cardiac fibroblast migration is differentially
regulated by a number of factors. Diabetic cells tend to have higher migration levels than
non-diabetic fibroblasts. In addition, the accumulation of AGEs in diabetic collagen,
which activates the intact AGE/RAGE signaling cascade, will lessens migration in
comparison to that observed in RAGE knockout cells. Lastly, collagen isolated from mice
with the presence or absence of RAGE will not alter cell migration. Changes in cell
migration and the factors that influence cell behavior have the potential to alter organ
performance. For example, left ventricle hypertrophy caused by myocardial stiffening is
one of the most common cardiovascular complication diabetic individuals will develop
over time.7,47 One reason for this stiffening is the build-up of collagen or increased
collagen deposition secreted by active cardiac fibroblasts or myofibroblasts.45,47 Our
studies demonstrated cardiac fibroblast migration was modified based upon changes in
the cellular environment. Hyperglycemia as seen with diabetes, increased AGEs, and
active RAGE signaling will impact cell migration and, thus, collagen deposition by the
cardiac myofibroblasts resulting in progressive increases in left ventricle hypertrophy. By
generating therapeutics against the AGE/RAGE signaling pathway, there is the potential
to lessen diabetic complications, such as left ventricle hypertrophy, by inhibiting
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myofibroblast differentiation as well as migration of diabetic cardiac fibroblasts despite
signals received from the extracellular collagen.

Future Directions
In the future, we plan to use the knowledge gained regarding the impact cellular
genotypes have on migration to manipulate integral players in the AGE/RAGE signaling
pathway. More specifically, we plan to downregulate Rap1a to dampen overall outcomes
due to increased RAGE signaling. Signaling mechanisms, such as the AGE/RAGE
cascade, are oftentimes much more complicated and complex than studies report.
Therefore, finding molecules or small proteins, like Rap1a, provide a target to dampen
the signaling cascade without shutting it off completely as with knockout models.
Decreasing Rap1a activity or expression will reduce changes in fibroblast phenotype as
well as increase migratory behavior in order to minimize the long-term effects of diabetes
and improve wound healing. Modulating the AGE/RAGE cascade will decrease collagen
accumulation and ventricular hypertrophy allowing diabetic hearts to maintain
performance and extend the life of patients suffering from the pathology.
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